In the latest close session, Microsoft (MSFT - Free Report) was up +2.15% at $402.29. The stock's performance was ahead of the S&P 500's daily loss of 0.19%. On the other hand, the Dow registered a loss of 0.59%, and the technology-centric Nasdaq decreased by 0.05%.
Coming into today, shares of the software maker had gained 3.8% in the past month. In that same time, the Computer and Technology sector lost 4.32%, while the S&P 500 gained 0.55%.
Market participants will be closely following the financial results of Microsoft in its upcoming release. The company plans to announce its earnings on July 29, 2026. The company is forecasted to report an EPS of $4.21, showcasing a 15.34% upward movement from the corresponding quarter of the prior year. At the same time, our most recent consensus estimate is projecting a revenue of $87.42 billion, reflecting a 14.36% rise from the equivalent quarter last year.
MSFT's full-year Zacks Consensus Estimates are calling for earnings of $17.33 per share and revenue of $329.24 billion. These results would represent year-over-year changes of +27.05% and +16.87%, respectively.
Any recent changes to analyst estimates for Microsoft should also be noted by investors. These latest adjustments often mirror the shifting dynamics of short-term business patterns. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 0.16% higher within the past month. Currently, Microsoft is carrying a Zacks Rank of #3 (Hold).
Investors should also note Microsoft's current valuation metrics, including its Forward P/E ratio of 20.39. This represents a premium compared to its industry average Forward P/E of 15.74.
Also, we should mention that MSFT has a PEG ratio of 1.19. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. MSFT's industry had an average PEG ratio of 1.32 as of yesterday's close.
The Computer - Software industry is part of the Computer and Technology sector. This industry, currently bearing a Zacks Industry Rank of 102, finds itself in the top 42% echelons of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.
In the latest close session, Advanced Micro Devices (AMD - Free Report) was up +1.58% at $503.57. The stock outperformed the S&P 500, which registered a daily loss of 0.19%. Elsewhere, the Dow lost 0.59%, while the tech-heavy Nasdaq lost 0.05%.
Heading into today, shares of the chipmaker had lost 7.74% over the past month, lagging the Computer and Technology sector's loss of 4.32% and the S&P 500's gain of 0.55%.
The upcoming earnings release of Advanced Micro Devices will be of great interest to investors. The company's earnings report is expected on August 4, 2026. The company is forecasted to report an EPS of $1.6, showcasing a 233.33% upward movement from the corresponding quarter of the prior year. Meanwhile, the latest consensus estimate predicts the revenue to be $11.32 billion, indicating a 47.24% increase compared to the same quarter of the previous year.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $7.3 per share and revenue of $49.29 billion. These totals would mark changes of +75.06% and +42.31%, respectively, from last year.
Investors should also pay attention to any latest changes in analyst estimates for Advanced Micro Devices. Such recent modifications usually signify the changing landscape of near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the past month, there's been a 1.05% rise in the Zacks Consensus EPS estimate. Advanced Micro Devices is currently sporting a Zacks Rank of #3 (Hold).
Digging into valuation, Advanced Micro Devices currently has a Forward P/E ratio of 67.95. This signifies a premium in comparison to the average Forward P/E of 22.7 for its industry.
We can also see that AMD currently has a PEG ratio of 1.23. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. The Computer - Integrated Systems was holding an average PEG ratio of 0.89 at yesterday's closing price.
The Computer - Integrated Systems industry is part of the Computer and Technology sector. At present, this industry carries a Zacks Industry Rank of 19, placing it within the top 8% of over 250 industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Alibaba Group Holding Limited (NYSE: BABA) resulting from allegations that Alibaba may have issued materially misleading business information to the investing public.
So What: If you purchased Alibaba securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.
What to do next: To join the prospective class action, go to https://rosenlegal.com/cases/alibaba-group-holding-limited/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
What is this about: On June 24, 2026, Financial Times published an article entitled "Anthropic accuses Alibaba of obtaining illicit access to Claude". The article stated that Anthropic has "accused Chinese ecommerce giant Alibaba of obtaining illicit access to Claude by creating fake accounts designed to access the AI model which the American company does not offer to Chinese groups."
On this news, Alibaba American Depositary Shares ("ADS") fell 2.7% on June 24, 2026.
Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com
In the latest trading session, Tilray Brands, Inc. (TLRY - Free Report) closed at $4.23, marking a -1.63% move from the previous day. This change lagged the S&P 500's daily loss of 0.19%. Elsewhere, the Dow lost 0.59%, while the tech-heavy Nasdaq lost 0.05%.
The stock of company has fallen by 9.09% in the past month, lagging the Medical sector's gain of 6.06% and the S&P 500's gain of 0.55%.
Investors will be eagerly watching for the performance of Tilray Brands, Inc. in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on July 28, 2026. The company is expected to report EPS of -$0.01, down 105% from the prior-year quarter. Simultaneously, our latest consensus estimate expects the revenue to be $268.17 million, showing a 19.43% escalation compared to the year-ago quarter.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of -$0.58 per share and a revenue of $885.3 million, indicating changes of -680% and +7.79%, respectively, from the former year.
Investors might also notice recent changes to analyst estimates for Tilray Brands, Inc. These recent revisions tend to reflect the evolving nature of short-term business trends. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate remained stagnant. Tilray Brands, Inc. presently features a Zacks Rank of #3 (Hold).
The Medical - Products industry is part of the Medical sector. With its current Zacks Industry Rank of 169, this industry ranks in the bottom 32% of all industries, numbering over 250.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.
Netflix (NFLX 1.99%) reported earnings last week, and the numbers didn't give investors much of a reason to be bullish. The results weren't bad, as the company generated solid double-digit growth, but investors remained concerned about its future, as the guidance didn't provide enough assurance that the business is on the right path.
Earlier this year, Netflix's stock went into a tailspin after investors learned co-founder Reed Hastings was leaving the company. And amid continued questions about its future growth prospects, investors are even more bearish of late.
But could Netflix, which is still very much a leader in its industry, make for a good investment, especially with its stock now dipping below $70 and being the lowest it's been in nearly two years?
Image source: Getty Images.
Netflix's Q2 numbers were mixed, and its guidance was soft For the second quarter, which ended on June 30, Netflix's earnings per share totaled $0.80, a penny above analyst estimates. Meanwhile, revenue of $12.56 billion narrowly missed Wall Street expectations of $12.59 billion. While it was technically a miss, the company came very close to meeting expectations. Its revenue was up 13% year over year.
But with the company's guidance calling for just 12% growth for the current quarter amid questions about how engaged users are with its shows -- there have been concerns about a drop-off after a show's first season -- it may have simply reinforced investors' concerns about the business moving forward. The unconvincing results led the stock to fall after the release of the earnings results, hitting a new 52-week low of $65.08 on Friday.
Today's Change
(
-1.99
%) $
-1.37
Current Price
$
67.58
Has Netflix stock become a cheap buy? In the past 12 months, Netflix's stock has declined by 44%. It's currently trading at around 21 times its trailing earnings, which is relatively cheap given that the average S&P 500 stock trades at a multiple of more than 25. Netflix is modestly priced by comparison, especially given its reasonably solid growth numbers.
While Netflix's growth rate is slowing down, it's not a steep enough drop-off to suggest that there is something fundamentally wrong with the business. The market may be overreacting, as the stock still hasn't recovered from the news of Hastings' departure.
However, with excellent fundamentals and the streaming stock trading at a reasonable valuation, I think Netflix can make for a great buy right now.
The ETF market saw inflows shift notably this past week, as investors funneled capital toward international valuation gaps and domestic large-cap equities. This, coupled with aggressive buying in the semiconductor sector amid a market drawdown, highlights continued investor appetite for growth despite broader market fluctuations.
Key Takeaways Investors directed $3.03 billion into the iShares MSCI South Korea ETF (EWY) to bypass the high premiums associated with the recently listed U.S. ADRs while the issuance and cancellation books remain closed until July 29. Capital continued to flow into U.S. large-cap equity funds, with the State Street SPDR Portfolio S&P 500 ETF (SPYM) gaining $1.82 billion and the Invesco NASDAQ 100 ETF (QQQM) drawing $1.08 billion, while investors also allocated $1.47 billion to the iShares MSCI Value ETF (EFV) to hedge against U.S. tech-heavy market concentration. Despite a July pullback, capital flooded into the semiconductor sector. The iShares Semiconductor ETF (SOXX) gained $2.40 billion. Meanwhile, the Direxion Daily Semiconductor Bull 3X ETF (SOXL) recorded $1.38 billion in inflows. The Roundhill Memory ETF (DRAM) attracted $1.66 billion as investors continue to seek exposure to AI-driven memory shortages. Bypassing the SK Hynix ADR Premium The iShares MSCI South Korea ETF (EWY) led inflows last week, gaining $3.03 billion. This spike in inflows is primarily driven by investors using the fund as a proxy to gain exposure to SK Hynix (SKHY), as the newly launched American Depository Receipts (ADRs) have traded at a substantial premium compared to local shares on the Korea Exchange.
SK Hynix ADRs traded at a premium of approximately 27% as of last Thursday afternoon, following a record 51% premium the prior day, according to Bloomberg analysis. The price difference between South Korean shares and U.S. ADRs of SK Hynix remains constrained as the ADR books are closed for issuance and cancellation until July 29, following the official listing date of the newly issued common shares in the South Korean market.
Rather than paying the premium for U.S.-listed ADRs, investors are pouring capital into EWY, where SK Hynix is the top holding, representing 24.18% of the portfolio. The fund functions as a cheaper method of gaining exposure to the underlying Korean shares.
Large-Cap Momentum and International Value While headlines focused on South Korean markets, investors continued to allocate capital into U.S. large-cap equity funds. The State Street SPDR Portfolio S&P 500 ETF (SPYM) saw inflows of $1.82 billion last week, while the more concentrated Invesco NASDAQ 100 ETF (QQQM) saw inflows of $1.08 billion over the same period.
For investors seeking exposure to international large- and mid-cap value stocks, the iShares MSCI EAFE Value ETF (EFV) saw inflows of $1.47 billion during the past week. Investors continue to pour capital into international value funds to seek cheaper valuations and hedge against mega-cap tech-dominated U.S. market concentration.
Capitalizing on the July Pullback Despite the semiconductor market having seen a pullback in July, investors are aggressively buying into the dip, likely viewing it as a buying opportunity rather than a sign that the sector has reached its peak.
The iShares Semiconductor ETF (SOXX), which provides exposure to roughly 30 U.S.-listed semiconductor companies, saw inflows of $2.40 billion last week. Tracking the same index, the Direxion Daily Semiconductor Bull 3X ETF (SOXL) seeks to provide 300% of the daily performance of the underlying ICE Semiconductor Index. SOXL recorded inflows of $1.38 billion over the past week.
Looking specifically at the memory semiconductor market, the Roundhill Memory ETF (DRAM), which is down over 30% from its June highs, pulled in $1.66 billion during last week’s trading. Investors continue to commit capital to the memory component industry as AI-driven memory shortages persist.
Capitalizing on Financial Earnings and Recent ETF Debuts The State Street Financial Select Sector SPDR ETF (XLF) attracted $962.88 million last week, driven by strong second-quarter earnings growth across top holdings such as JPMorgan (JPM) and cooling U.S. inflation data that has eased rate hike pressures.
Two recently launched ETFs also saw significant inflows over the past week. The SEI QiM U.S. Equity Factor Allocation Active ETF (SEUS), which launched on July 14, recorded inflows of $886.13 million. The fund targets U.S. equities using proprietary factor research and integrated risk models to adapt to evolving market conditions.
The Fidelity MSCI North American Subset Index ETF (FINA) launched on July 9 and attracted $853.50 million in assets last week, largely driven by institutional interest in climate-aligned core equity exposure. The fund targets large- and mid-cap U.S. and Canadian stocks that meet emissions reduction targets approved by the Science Based Targets initiative (SBTi).
For more news, information, and analysis, visit the Equity ETF Content Hub.
Walt Disney Co (NYSE:DIS, XETRA:WDP) is scheduled to report fiscal third quarter results on August 5, with UBS analysts expecting accelerating earnings growth as first-half headwinds ease and forecasting the company will maintain its fiscal 2026 guidance.
UBS expects Disney to report fiscal third-quarter revenue of $25.4 billion and segment operating income of $5.16 billion, compared with Wall Street expectations of $5.24 billion and company guidance of about $5.3 billion.
The firm forecasts earnings per share of $1.91, above the consensus estimate of $1.85 and up 18% from a year earlier.
The analysts wrote that growth should be supported by high single-digit expansion in the Experiences segment and double-digit growth in the company's streaming business, while Sports operating income is expected to decline by the mid-teens due to higher sports rights costs. They also expect box office performance to remain soft overall.
For fiscal 2026, UBS continues to forecast earnings per share of $6.90, representing 16% year-over-year growth and broadly in line with Disney's guidance. The estimate includes a roughly 4% benefit from an extra week in the fiscal fourth quarter and is expected to be driven by continued strength in Experiences, improving Sports profitability and streaming margins above 10%.
In Experiences, UBS expects revenue to rise 8.7% year over year and operating income to increase 9.6% as the business laps upfront cruise costs and pre-opening expenses related to World of Frozen. The analysts expect growth to accelerate further in the fourth quarter before receiving an additional boost from the extra fiscal week.
UBS believes domestic attendance improved during the quarter, with attendance roughly flat from a year earlier after declining 1% in the prior quarter, as comparisons related to Epic Universe's opening and international visitation became less challenging. Per-capita guest spending is expected to remain strong, increasing about 4% year over year.
Within Entertainment, UBS forecasts revenue growth of 8.7% and operating income growth of 48% to approximately $1.5 billion, driven by streaming gains and the consolidation of Fubo. The analysts expect streaming subscription revenue to increase 11% year over year, while streaming operating margins improve by 350 basis points from a year earlier to 10.1%, despite sequential pressure from higher international content spending.
The analysts also expect mixed theatrical performance during the quarter, citing stronger box office results from The Devil Wears Prada 2 and Toy Story 5, offset by weaker performances from Star Wars: The Mandalorian & Grogu and the live-action Moana.
In Sports, UBS forecasts revenue growth of 4.7%, including an approximately 3% contribution from NFL Network, while operating income is expected to decline 14% to $891 million as double-digit growth in sports rights expenses, including NBA and WWE contracts, weighs on profitability.
The analysts expect advertising revenue to increase more than 10% on stronger NBA ratings and noted that Disney recorded its first quarter of year-over-year television viewership growth since the first quarter of 2024, helped by NBA Finals audiences. UBS expects subscription and affiliate revenue growth of around 5%, with streaming gains partly offset by the NFL Network no longer being carried on Comcast's Xfinity platform.
UBS also noted that management expects mid-single-digit operating income growth for the Sports segment for the full fiscal year, with the firm anticipating a stronger fourth quarter supported by easier comparisons related to sports rights costs and last year's ESPN direct-to-consumer launch expenses.
McDonald's stock price has crashed by over 20% in less than 5 months. For me, that's a very attractive buy-the-dip opportunity. MCD's scalable franchise model, robust free cash flow, and Dividend Aristocrat status underpin shareholder rewards and ongoing expansion.
Novavax (NVAX - Free Report) ended the recent trading session at $7.88, demonstrating a -4.02% change from the preceding day's closing price. This move lagged the S&P 500's daily loss of 0.19%. Meanwhile, the Dow experienced a drop of 0.59%, and the technology-dominated Nasdaq saw a decrease of 0.05%.
Prior to today's trading, shares of the vaccine maker had lost 10.08% lagged the Medical sector's gain of 6.06% and the S&P 500's gain of 0.55%.
The upcoming earnings release of Novavax will be of great interest to investors. The company's upcoming EPS is projected at -$0.36, signifying a 158.06% drop compared to the same quarter of the previous year. Meanwhile, our latest consensus estimate is calling for revenue of $50.04 million, down 79.08% from the prior-year quarter.
For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of -$0.19 per share and a revenue of $371.85 million, representing changes of -107.36% and -66.9%, respectively, from the prior year.
Investors should also take note of any recent adjustments to analyst estimates for Novavax. These latest adjustments often mirror the shifting dynamics of short-term business patterns. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability.
Our research shows that these estimate changes are directly correlated with near-term stock prices. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has remained steady. Novavax currently has a Zacks Rank of #1 (Strong Buy).
The Medical - Biomedical and Genetics industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 98, which puts it in the top 40% of all 250+ industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.
Moderna (MRNA 3.77%) soared onto the scene in early pandemic days with its messenger RNA technology and delivered a coronavirus vaccine in a matter of months. As the vaccine brought in blockbuster revenue, Moderna's stock price roared higher. In fact, from the start of 2020 through early August 2021, it climbed more than 2,000%.
In recent years, as demand for the coronavirus vaccine declined, the biotech company also saw its profits shrink and even turn into losses. And though the pipeline remained robust, investors had difficulty seeing Moderna as more than a coronavirus vaccine player. All of this led to declines in the stock price, with it sliding more than 80% from its peak.
But Moderna has made significant progress advancing pipeline programs and cost-cutting efforts, and this year, investors have been sitting up and taking notice. The stock has skyrocketed, climbing 109%. Jim Cramer of CNBC's Mad Money calls it "finally investable again." Is Moderna a no-brainer buy on its recent pullback? Let's find out.
Image source: Getty Images.
Moderna's disappointments As mentioned, Moderna struggled in recent years as it took time to transition from a coronavirus vaccine company to a player that investors could see as a multi-product company across treatment areas. Moderna faced its share of disappointments along the path, too, with its respiratory syncytial virus (RSV) vaccine delivering sales that fell short of expectations during its first season on the market and its cytomegalovirus (CMV) candidate failing in late-stage trials.
These sorts of setbacks aren't uncommon for biotech and pharma companies, but following the decline in coronavirus vaccine sales, they added to Moderna's difficulties. But the biotech company progressed in its efforts to realign costs with its opportunities and advance promising programs.
In the latest quarterly update, Moderna reiterated its goal of generating as much as 10% revenue growth this year. And in the quarter, the company delivered a 26% reduction in adjusted cash costs.
Moderna currently has three approved products in the U.S. -- two coronavirus vaccines and its RSV vaccine -- and it may be on the way to launching a fourth. Regulators currently are reviewing the company's flu vaccine candidate, mRNA-1010, and a decision is expected on or before Aug. 5. The company also recently won approval in Europe for its combined coronavirus/flu vaccine -- the world's first.
Today's Change
(
-3.77
%) $
-2.33
Current Price
$
59.49
Future growth drivers Moderna's late-stage candidates and commercialized medicine focus areas are infectious disease vaccines, rare diseases, and oncology. And here, late-stage candidates may drive significant growth in the coming years. For example, intismeran autogene, a personalized cancer therapy, is being studied in several phase 3 trials, and the company's propionic acidemia study is fully enrolled, with data expected later this year. This study may support a regulatory submission.
"Moderna's got a plethora of thoughtful, new products and clear roadmap to profitability for the first time in such a long time," said CNBC's Jim Cramer.
Meanwhile, Moderna stock, though it's soared more than 100% this year, has declined 24% from a peak on July 6. Is the stock a no-brainer buy after this pullback? Moderna is a buy, but investors shouldn't rush to get in on the stock immediately. At today's level, it's reasonable to pick up the shares, but I wouldn't expect them to soar overnight to an out-of-reach price.
Your decision may depend on your investing strategy. Cautious investors might wait a bit longer as Moderna's late-stage candidates progress and then consider picking up a few shares. Aggressive investors, however, may aim to start building a position today, on the dip, and potentially add to this position over time.
Even if Moderna's performance in the second half of the year isn't as spectacular as it was in the first half, that's OK -- the company clearly has reached a key transition point on its path to becoming a multi-product player addressing numerous treatment areas. And that makes it a fantastic stock to buy now or in the coming quarters and hold onto for the long term.
Moderna (MRNA - Free Report) closed at $59.49 in the latest trading session, marking a -3.77% move from the prior day. This move lagged the S&P 500's daily loss of 0.19%. Meanwhile, the Dow experienced a drop of 0.59%, and the technology-dominated Nasdaq saw a decrease of 0.05%.
The biotechnology company's stock has dropped by 3.35% in the past month, falling short of the Medical sector's gain of 6.06% and the S&P 500's gain of 0.55%.
Investors will be eagerly watching for the performance of Moderna in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on July 31, 2026. The company is expected to report EPS of -$1.97, up 7.51% from the prior-year quarter. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $126.65 million, down 10.81% from the year-ago period.
MRNA's full-year Zacks Consensus Estimates are calling for earnings of -$8.64 per share and revenue of $2.09 billion. These results would represent year-over-year changes of -19.01% and +7.28%, respectively.
It is also important to note the recent changes to analyst estimates for Moderna. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 1.51% upward. Currently, Moderna is carrying a Zacks Rank of #3 (Hold).
The Medical - Biomedical and Genetics industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 98, which puts it in the top 40% of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.
In the latest close session, Adobe Systems (ADBE - Free Report) was down 1.06% at $234.74. This change lagged the S&P 500's 0.19% loss on the day. At the same time, the Dow lost 0.59%, and the tech-heavy Nasdaq lost 0.05%.
Shares of the software maker witnessed a gain of 21.57% over the previous month, beating the performance of the Computer and Technology sector with its loss of 4.32%, and the S&P 500's gain of 0.55%.
Analysts and investors alike will be keeping a close eye on the performance of Adobe Systems in its upcoming earnings disclosure. It is anticipated that the company will report an EPS of $6.08, marking a 14.5% rise compared to the same quarter of the previous year. Meanwhile, our latest consensus estimate is calling for revenue of $6.67 billion, up 11.38% from the prior-year quarter.
For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of $24.31 per share and a revenue of $26.52 billion, representing changes of +16.09% and +11.58%, respectively, from the prior year.
It is also important to note the recent changes to analyst estimates for Adobe Systems. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 0.02% increase. Right now, Adobe Systems possesses a Zacks Rank of #3 (Hold).
Valuation is also important, so investors should note that Adobe Systems has a Forward P/E ratio of 9.76 right now. This valuation marks a discount compared to its industry average Forward P/E of 15.74.
We can also see that ADBE currently has a PEG ratio of 0.65. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. The Computer - Software industry currently had an average PEG ratio of 1.32 as of yesterday's close.
The Computer - Software industry is part of the Computer and Technology sector. Currently, this industry holds a Zacks Industry Rank of 102, positioning it in the top 42% of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.
Pfizer (PFE - Free Report) ended the recent trading session at $24.75, demonstrating a -1.2% change from the preceding day's closing price. The stock's change was less than the S&P 500's daily loss of 0.19%. Meanwhile, the Dow experienced a drop of 0.59%, and the technology-dominated Nasdaq saw a decrease of 0.05%.
Prior to today's trading, shares of the drugmaker had lost 0.63% lagged the Medical sector's gain of 6.06% and the S&P 500's gain of 0.55%.
The investment community will be paying close attention to the earnings performance of Pfizer in its upcoming release. The company is slated to reveal its earnings on August 4, 2026. The company is expected to report EPS of $0.68, down 12.82% from the prior-year quarter. Meanwhile, the latest consensus estimate predicts the revenue to be $14.45 billion, indicating a 1.39% decrease compared to the same quarter of the previous year.
Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $2.96 per share and revenue of $61.86 billion, indicating changes of -8.07% and -1.16%, respectively, compared to the previous year.
Investors should also take note of any recent adjustments to analyst estimates for Pfizer. These latest adjustments often mirror the shifting dynamics of short-term business patterns. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 1% lower. Pfizer is holding a Zacks Rank of #3 (Hold) right now.
From a valuation perspective, Pfizer is currently exchanging hands at a Forward P/E ratio of 8.47. This signifies a discount in comparison to the average Forward P/E of 16.49 for its industry.
The Large Cap Pharmaceuticals industry is part of the Medical sector. This group has a Zacks Industry Rank of 231, putting it in the bottom 7% of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.
In the latest close session, Cisco Systems (CSCO - Free Report) was down 1.11% at $110.70. The stock's performance was behind the S&P 500's daily loss of 0.19%. At the same time, the Dow lost 0.59%, and the tech-heavy Nasdaq lost 0.05%.
Shares of the seller of routers, switches, software and services witnessed a loss of 6.36% over the previous month, trailing the performance of the Computer and Technology sector with its loss of 4.32%, and the S&P 500's gain of 0.55%.
Investors will be eagerly watching for the performance of Cisco Systems in its upcoming earnings disclosure. The company's upcoming EPS is projected at $1.17, signifying a 18.18% increase compared to the same quarter of the previous year. Meanwhile, the latest consensus estimate predicts the revenue to be $16.85 billion, indicating a 14.86% increase compared to the same quarter of the previous year.
CSCO's full-year Zacks Consensus Estimates are calling for earnings of $4.28 per share and revenue of $62.95 billion. These results would represent year-over-year changes of +12.34% and +11.11%, respectively.
Any recent changes to analyst estimates for Cisco Systems should also be noted by investors. These latest adjustments often mirror the shifting dynamics of short-term business patterns. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 0.04% upward. Right now, Cisco Systems possesses a Zacks Rank of #2 (Buy).
Looking at valuation, Cisco Systems is presently trading at a Forward P/E ratio of 26.14. This represents a premium compared to its industry average Forward P/E of 19.52.
We can also see that CSCO currently has a PEG ratio of 2.36. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. The Computer - Networking industry had an average PEG ratio of 1.75 as trading concluded yesterday.
The Computer - Networking industry is part of the Computer and Technology sector. This group has a Zacks Industry Rank of 199, putting it in the bottom 20% of all 250+ industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.
A Pill That Does An Injection’s JobWho Are The Biggest Winners?The clearest winners are patients who need more than a statin and have resisted the needle. That includes people with heterozygous familial hypercholesterolemia, a genetic condition that drives LDL dangerously high, along with the large group who remain above their target despite maximum statin therapy or who cannot tolerate statins at all.
With this pill, the chances of these people adhering to their drugs are much higher. With a once daily pill that fits into a routine that already includes other tablets, patients who balked at self-injection now have a reason to keep going. Better adherence to LDL-lowering therapy tends to translate into fewer cardiovascular events over time, which is the entire point of treating high cholesterol in the first place.
The Price Tag And The Evidence GapHowever, there is an important caveat regarding this drug. Lipfendra earned approval on its ability to lower LDL, not yet on proof that it prevents heart attacks and strokes, since the large cardiovascular outcomes trial is still running. The LDL reduction is a strong signal, and the injectable PCSK9 drugs have shown outcomes benefits, but the definitive event data for the pill is not in hand.
The bull case for Merck rests on convenience, price, and a huge addressable market. The risks are equally clear, since pending outcome data, aggressive formulary negotiations, and rebate economics could all cap how much pricing power the launch really has.
What To Watch From HerePatients who remain above their LDL goal, especially those who have avoided the injectable options, now have a reason to revisit the conversation with their doctor. Investors have a cleaner scorecard, since early prescription uptake, formulary placement, and the eventual cardiovascular outcomes results will show whether the first cholesterol pill becomes a blockbuster or merely a convenient alternative.
None of this is investment advice, and readers weighing either the medication or the stocks should confirm current details with their physician, their insurer, and their own research before acting.
Benzinga Disclaimer: This article is from an unpaid external contributor. It does not represent Benzinga’s reporting and has not been edited for content or accuracy.
Market News and Data brought to you by Benzinga APIs
Merck (MRK - Free Report) closed at $124.40 in the latest trading session, marking a -2.43% move from the prior day. The stock's performance was behind the S&P 500's daily loss of 0.19%. Meanwhile, the Dow lost 0.59%, and the Nasdaq, a tech-heavy index, lost 0.05%.
Heading into today, shares of the pharmaceutical company had gained 11.97% over the past month, outpacing the Medical sector's gain of 6.06% and the S&P 500's gain of 0.55%.
Market participants will be closely following the financial results of Merck in its upcoming release. The company plans to announce its earnings on August 4, 2026. The company is predicted to post an EPS of -$0.26, indicating a 112.21% decline compared to the equivalent quarter last year. Meanwhile, the latest consensus estimate predicts the revenue to be $16.33 billion, indicating a 3.32% increase compared to the same quarter of the previous year.
For the annual period, the Zacks Consensus Estimates anticipate earnings of $2.76 per share and a revenue of $66.75 billion, signifying shifts of -69.27% and +2.68%, respectively, from the last year.
Investors should also take note of any recent adjustments to analyst estimates for Merck. Recent revisions tend to reflect the latest near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 46.53% lower. Currently, Merck is carrying a Zacks Rank of #4 (Sell).
Digging into valuation, Merck currently has a Forward P/E ratio of 46.14. This signifies a premium in comparison to the average Forward P/E of 16.49 for its industry.
Investors should also note that MRK has a PEG ratio of 5.04 right now. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. MRK's industry had an average PEG ratio of 2.65 as of yesterday's close.
The Large Cap Pharmaceuticals industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 231, which puts it in the bottom 7% of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow MRK in the coming trading sessions, be sure to utilize Zacks.com.
Macy's (M - Free Report) closed the most recent trading day at $23.31, moving -1.56% from the previous trading session. This change lagged the S&P 500's 0.19% loss on the day. Elsewhere, the Dow saw a downswing of 0.59%, while the tech-heavy Nasdaq depreciated by 0.05%.
The department store operator's stock has dropped by 1.91% in the past month, falling short of the Retail-Wholesale sector's gain of 2.41% and the S&P 500's gain of 0.55%.
Analysts and investors alike will be keeping a close eye on the performance of Macy's in its upcoming earnings disclosure. In that report, analysts expect Macy's to post earnings of $0.35 per share. This would mark a year-over-year decline of 14.63%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $4.81 billion, down 0.09% from the year-ago period.
M's full-year Zacks Consensus Estimates are calling for earnings of $2.19 per share and revenue of $21.76 billion. These results would represent year-over-year changes of -5.6% and -0.01%, respectively.
Investors might also notice recent changes to analyst estimates for Macy's. Such recent modifications usually signify the changing landscape of near-term business trends. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 1.36% upward. Macy's currently has a Zacks Rank of #3 (Hold).
From a valuation perspective, Macy's is currently exchanging hands at a Forward P/E ratio of 10.8. Its industry sports an average Forward P/E of 14.15, so one might conclude that Macy's is trading at a discount comparatively.
The Retail - Regional Department Stores industry is part of the Retail-Wholesale sector. This group has a Zacks Industry Rank of 102, putting it in the top 42% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
Emerson Electric (EMR - Free Report) closed the most recent trading day at $136.58, moving -2.12% from the previous trading session. This change lagged the S&P 500's 0.19% loss on the day. At the same time, the Dow lost 0.59%, and the tech-heavy Nasdaq lost 0.05%.
The maker of process controls systems, valves and analytical instruments's stock has dropped by 7.38% in the past month, falling short of the Industrial Products sector's loss of 2.49% and the S&P 500's gain of 0.55%.
Market participants will be closely following the financial results of Emerson Electric in its upcoming release. The company plans to announce its earnings on August 4, 2026. The company's earnings per share (EPS) are projected to be $1.68, reflecting a 10.53% increase from the same quarter last year. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $4.79 billion, up 5.3% from the year-ago period.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $6.49 per share and revenue of $18.79 billion. These totals would mark changes of +8.17% and +4.28%, respectively, from last year.
Any recent changes to analyst estimates for Emerson Electric should also be noted by investors. These latest adjustments often mirror the shifting dynamics of short-term business patterns. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the past month, there's been a 0.08% fall in the Zacks Consensus EPS estimate. Emerson Electric presently features a Zacks Rank of #4 (Sell).
In terms of valuation, Emerson Electric is presently being traded at a Forward P/E ratio of 21.5. This represents a discount compared to its industry average Forward P/E of 23.05.
We can also see that EMR currently has a PEG ratio of 2.23. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. As the market closed yesterday, the Manufacturing - Electronics industry was having an average PEG ratio of 1.61.
The Manufacturing - Electronics industry is part of the Industrial Products sector. This group has a Zacks Industry Rank of 102, putting it in the top 42% of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.
American Tower (AMT - Free Report) closed at $167.06 in the latest trading session, marking a -1.76% move from the prior day. The stock trailed the S&P 500, which registered a daily loss of 0.19%. Elsewhere, the Dow lost 0.59%, while the tech-heavy Nasdaq lost 0.05%.
Coming into today, shares of the wireless communications infrastructure company had lost 3.4% in the past month. In that same time, the Finance sector gained 2.54%, while the S&P 500 gained 0.55%.
The investment community will be closely monitoring the performance of American Tower in its forthcoming earnings report. The company is scheduled to release its earnings on July 28, 2026. The company's upcoming EPS is projected at $2.71, signifying a 4.23% increase compared to the same quarter of the previous year. Meanwhile, our latest consensus estimate is calling for revenue of $2.71 billion, up 3.09% from the prior-year quarter.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $10.97 per share and a revenue of $10.91 billion, indicating changes of +1.95% and +2.53%, respectively, from the former year.
Any recent changes to analyst estimates for American Tower should also be noted by investors. These revisions typically reflect the latest short-term business trends, which can change frequently. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has remained steady. Currently, American Tower is carrying a Zacks Rank of #3 (Hold).
Investors should also note American Tower's current valuation metrics, including its Forward P/E ratio of 15.5. This indicates a premium in contrast to its industry's Forward P/E of 13.91.
It's also important to note that AMT currently trades at a PEG ratio of 0.69. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. REIT and Equity Trust - Other stocks are, on average, holding a PEG ratio of 2.31 based on yesterday's closing prices.
The REIT and Equity Trust - Other industry is part of the Finance sector. Currently, this industry holds a Zacks Industry Rank of 56, positioning it in the top 23% of all 250+ industries.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Hyliion Holdings Corp. (NYSE American: HYLN) resulting from allegations that Hyliion may have issued materially misleading business information to the investing public.
So What: If you purchased Hyliion securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.
What to do next: To join the prospective class action, go to https://rosenlegal.com/cases/hyliion-holdings-corp/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
What is this about: On June 23, 2026, Investing.com published an article entitled "Hyliion stock tumbles on short seller report questioning VFG deal". The article stated that Hyliion shares fell "following the release of a short report by Pelican Way Research questioning the legitimacy of a key customer agreement that had previously sent the stock surging approximately 150%."
On this news, Hyliion stock fell 17.2% on June 23, 2026.
Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
In the latest close session, United Parcel Service (UPS - Free Report) was down 3.88% at $113.15. The stock's performance was behind the S&P 500's daily loss of 0.19%. Meanwhile, the Dow lost 0.59%, and the Nasdaq, a tech-heavy index, lost 0.05%.
Coming into today, shares of the package delivery service had gained 12.26% in the past month. In that same time, the Transportation sector gained 5.57%, while the S&P 500 gained 0.55%.
The upcoming earnings release of United Parcel Service will be of great interest to investors. The company's earnings report is expected on July 28, 2026. The company is expected to report EPS of $1.65, up 6.45% from the prior-year quarter. Simultaneously, our latest consensus estimate expects the revenue to be $21.75 billion, showing a 2.5% escalation compared to the year-ago quarter.
For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of $7.1 per share and a revenue of $90.32 billion, representing changes of -0.84% and +1.87%, respectively, from the prior year.
Investors should also take note of any recent adjustments to analyst estimates for United Parcel Service. Recent revisions tend to reflect the latest near-term business trends. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 0.02% higher. Right now, United Parcel Service possesses a Zacks Rank of #3 (Hold).
Investors should also note United Parcel Service's current valuation metrics, including its Forward P/E ratio of 16.57. This denotes a discount relative to the industry average Forward P/E of 17.61.
It is also worth noting that UPS currently has a PEG ratio of 1.87. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. Transportation - Air Freight and Cargo stocks are, on average, holding a PEG ratio of 1.79 based on yesterday's closing prices.
The Transportation - Air Freight and Cargo industry is part of the Transportation sector. This industry currently has a Zacks Industry Rank of 102, which puts it in the top 42% of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of First Solar, Inc. (NASDAQ: FSLR) between February 26, 2025 and February 24, 2026, inclusive (the “Class Period”), of the important August 24, 2026 lead plaintiff deadline.
SO WHAT: If you purchased First Solar securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the First Solar class action, go to https://rosenlegal.com/cases/first-solar-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 24, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made materially false and misleading statements and/or failed to disclose that: (1) defendants had overstated First Solar’s capacity to manage the impact of U.S. tariff policy on First Solar’s business; (2) defendants understated the extent to which its responses to U.S. tariff policy, including the intentional underutilization of production facilities in Malaysia and Vietnam, and attempted relocation of production to the U.S., were likely to negatively impact First Solar’s projected performance in the 2026 fiscal year; and (3) as a result, defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the First Solar class action, go to https://rosenlegal.com/cases/first-solar-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
-------------------------------
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827 [email protected]
www.rosenlegal.com
SolarEdge Technologies (SEDG - Free Report) closed at $48.61 in the latest trading session, marking a -9.09% move from the prior day. The stock fell short of the S&P 500, which registered a loss of 0.19% for the day. On the other hand, the Dow registered a loss of 0.59%, and the technology-centric Nasdaq decreased by 0.05%.
Shares of the photovoltaic products maker witnessed a loss of 7.89% over the previous month, trailing the performance of the Oils-Energy sector with its gain of 3.6%, and the S&P 500's gain of 0.55%.
Market participants will be closely following the financial results of SolarEdge Technologies in its upcoming release. The company plans to announce its earnings on August 5, 2026. The company's earnings per share (EPS) are projected to be $0.04, reflecting a 104.94% increase from the same quarter last year. Meanwhile, the latest consensus estimate predicts the revenue to be $341.66 million, indicating a 18.04% increase compared to the same quarter of the previous year.
For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of $0.05 per share and a revenue of $1.4 billion, representing changes of +102.1% and +18.44%, respectively, from the prior year.
Investors should also take note of any recent adjustments to analyst estimates for SolarEdge Technologies. These revisions help to show the ever-changing nature of near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 1.68% higher. SolarEdge Technologies is currently sporting a Zacks Rank of #3 (Hold).
Looking at valuation, SolarEdge Technologies is presently trading at a Forward P/E ratio of 984.97. This signifies a premium in comparison to the average Forward P/E of 19.81 for its industry.
The Solar industry is part of the Oils-Energy sector. Currently, this industry holds a Zacks Industry Rank of 56, positioning it in the top 23% of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
Enbridge (ENB - Free Report) ended the recent trading session at $55.73, demonstrating a -1.73% change from the preceding day's closing price. This move lagged the S&P 500's daily loss of 0.19%. Elsewhere, the Dow lost 0.59%, while the tech-heavy Nasdaq lost 0.05%.
The oil and natural gas transportation and power transmission company's stock has climbed by 3.96% in the past month, exceeding the Oils-Energy sector's gain of 3.6% and the S&P 500's gain of 0.55%.
Investors will be eagerly watching for the performance of Enbridge in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on July 31, 2026. In that report, analysts expect Enbridge to post earnings of $0.44 per share. This would mark a year-over-year decline of 6.38%. Alongside, our most recent consensus estimate is anticipating revenue of $11.03 billion, indicating a 2.59% upward movement from the same quarter last year.
ENB's full-year Zacks Consensus Estimates are calling for earnings of $2.14 per share and revenue of $48.4 billion. These results would represent year-over-year changes of -0.93% and +3.88%, respectively.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Enbridge. These revisions help to show the ever-changing nature of near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 1.74% lower. As of now, Enbridge holds a Zacks Rank of #3 (Hold).
In the context of valuation, Enbridge is at present trading with a Forward P/E ratio of 26.5. This indicates a premium in contrast to its industry's Forward P/E of 21.54.
The Oil and Gas - Production and Pipelines industry is part of the Oils-Energy sector. Currently, this industry holds a Zacks Industry Rank of 217, positioning it in the bottom 12% of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.
In the latest close session, RH (RH - Free Report) was down 2.09% at $183.95. This move lagged the S&P 500's daily loss of 0.19%. Meanwhile, the Dow lost 0.59%, and the Nasdaq, a tech-heavy index, lost 0.05%.
Shares of the furniture and housewares company witnessed a gain of 26.87% over the previous month, beating the performance of the Consumer Staples sector with its gain of 2.55%, and the S&P 500's gain of 0.55%.
The investment community will be closely monitoring the performance of RH in its forthcoming earnings report. The company is forecasted to report an EPS of $0.29, showcasing a 90.1% downward movement from the corresponding quarter of the prior year. Alongside, our most recent consensus estimate is anticipating revenue of $914.4 million, indicating a 1.7% upward movement from the same quarter last year.
For the annual period, the Zacks Consensus Estimates anticipate earnings of $4.73 per share and a revenue of $3.62 billion, signifying shifts of -24.8% and +5.11%, respectively, from the last year.
Investors should also note any recent changes to analyst estimates for RH. These revisions help to show the ever-changing nature of near-term business trends. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. RH is holding a Zacks Rank of #3 (Hold) right now.
In the context of valuation, RH is at present trading with a Forward P/E ratio of 39.69. This denotes a premium relative to the industry average Forward P/E of 19.68.
We can also see that RH currently has a PEG ratio of 3.89. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. As the market closed yesterday, the Consumer Products - Staples industry was having an average PEG ratio of 3.39.
The Consumer Products - Staples industry is part of the Consumer Staples sector. At present, this industry carries a Zacks Industry Rank of 190, placing it within the bottom 23% of over 250 industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
In the latest close session, Pinterest (PINS - Free Report) was down 1.68% at $22.81. The stock's change was less than the S&P 500's daily loss of 0.19%. Meanwhile, the Dow experienced a drop of 0.59%, and the technology-dominated Nasdaq saw a decrease of 0.05%.
The stock of digital pinboard and shopping tool company has risen by 14.45% in the past month, leading the Computer and Technology sector's loss of 4.32% and the S&P 500's gain of 0.55%.
The upcoming earnings release of Pinterest will be of great interest to investors. The company's earnings report is expected on August 4, 2026. It is anticipated that the company will report an EPS of $0.36, marking a 9.09% rise compared to the same quarter of the previous year. Meanwhile, our latest consensus estimate is calling for revenue of $1.15 billion, up 15.42% from the prior-year quarter.
For the annual period, the Zacks Consensus Estimates anticipate earnings of $1.92 per share and a revenue of $4.86 billion, signifying shifts of +20% and +15.01%, respectively, from the last year.
Investors might also notice recent changes to analyst estimates for Pinterest. Such recent modifications usually signify the changing landscape of near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 0.46% higher. Pinterest currently has a Zacks Rank of #3 (Hold).
From a valuation perspective, Pinterest is currently exchanging hands at a Forward P/E ratio of 12.07. This expresses a discount compared to the average Forward P/E of 20.12 of its industry.
It's also important to note that PINS currently trades at a PEG ratio of 0.45. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. As the market closed yesterday, the Internet - Software industry was having an average PEG ratio of 1.09.
The Internet - Software industry is part of the Computer and Technology sector. With its current Zacks Industry Rank of 91, this industry ranks in the top 37% of all industries, numbering over 250.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
HomeIndustriesComputers/ElectronicsTech StocksTech StocksMoonshot AI’s Kimi K3 could encourage a surge in enterprise workloads and provide a long-term tailwind to chip demandJuly 20, 2026, 6:21 p.m. ET
A cheap yet competitive artificial-intelligence model out of China has reignited the debate over the massive amounts of money that companies are spending on memory components and compute power.
But the emergence of low-cost Chinese AI isn’t necessarily a bad thing for U.S. semiconductor heavyweights that have seen their shares soar on strong demand for expensive AI hardware, according to some analysts. They reason that these chip companies could end up benefitting, even as AI costs go down.
AMC Entertainment Holdings (AMC +26.80%), the movie theater operator with U.S. and European cinema locations closed at $2.46, up 26.8%. The stock soared after Q2 results topped estimates, with investors now watching attendance, cash flow, and debt.
Trading volume reached 181.9 million shares, coming in about 342% above its three-month average of 41.1 million shares. AMC Entertainment Holdings IPO'd in 2013 and has fallen 99% since going public.
How the markets moved todayThe S&P 500 (^GSPC 0.19%) fell 0.19% to 7,443, and the Nasdaq Composite (^IXIC 0.05%) slipped 0.05% to 25,508. Among movie theater peers, Cinemark Holdings (CNK +5.00%) rose 5.10% to $31.97, while IMAX (IMAX 1.66%) fell 1.66% to $38.60, highlighting mixed sentiment across the group.
What this means for investorsIt was a double dose of good news for AMC Entertainment today. Second-quarter results beat expectations with reported adjusted earnings of $0.14 per share. It also generated $1.6 billion in revenue, marking the highest quarterly revenue and adjusted EBITDA in its 106-year history.
Additionally, the weekend’s box office, led by The Odyssey, brought more than 4.3 million moviegoers to AMC theaters globally.
CEO Adam Aron stated, “It is clear that our operating results so far this year are vastly improved. AMC has often been underestimated, and yet we continue to outperform.”
Investors clearly agreed with the stock soaring today. Investors still need to monitor the company’s debt level, as it raised billions to survive the extended slump triggered by the pandemic. AMC does look to have its business back on track, though, as long as movies continue to attract viewers.
Howard Smith has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
AMC weekly chart signs of reversal from long-term downtrend. Source: TradingView During Monday’s session, AMC gained approximately 26.8% to end at $2.46. That put the stock back above the 20-day moving average after confirming support near both the 50-day and 200-day moving averages over the past couple of weeks. This is bullish behavior that shows the continued reversal from a downtrend to an uptrend. The reclaim of the 200-day moving average is particularly notable since it follows an initial reclaim of that average during the advance in June. Maintaining this position above key moving averages would further strengthen the improving technical picture.
Resistance Levels Define the Next Test The progression of the rising trend channel structure suggests a potential target near the top boundary of the channel. However, the first upside target is the recent trend high of $2.96. If that level is exceeded, there is a small confluence zone defining an upside target near $3.25 to $3.32, consisting of the 50% retracement of a prior decline and the 100% projection of a rising ABCD pattern, respectively, that begins from the higher swing low in May.
During the June rally, resistance emerged at the confluence of a 61.8% Fibonacci retracement of a prior decline and the 161.8% Fibonacci projection of a prior rising ABCD pattern that forms the rising channel. A similar reaction near upcoming resistance levels will determine whether the current advance develops into a broader continuation of the emerging uptrend.
AMC Entertainment Holdings, Inc. delivered a strong Q2 FY2026, with revenue up 14.2% to $1.60 billion and adjusted EPS beating expectations. AMC saw 13.5% year-over-year attendance growth despite operating fewer theaters, benefiting from robust box office trends and higher food and beverage sales. Adjusted net profit surged to $105.7 million, adjusted EPS hit $0.14, and EBITDA rose to $321.4 million, with net debt reduced to $3.19 billion.
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Past performance is not an indicator of future performance. This post is illustrative and educational and is not a specific offer of products or services or financial advice. Information in this article is not an offer to buy or sell or a solicitation of any offer to buy or sell the securities mentioned herein. Information presented is believed to be factual and up-to-date, but we do not guarantee its accuracy, and it should not be regarded as a complete analysis of the subjects discussed. Expressions of opinion reflect the judgment of the authors as of the date of publication and are subject to change.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Teladoc (TDOC - Free Report) ended the recent trading session at $9.65, demonstrating a +2.33% change from the preceding day's closing price. This change outpaced the S&P 500's 0.19% loss on the day. Meanwhile, the Dow lost 0.59%, and the Nasdaq, a tech-heavy index, lost 0.05%.
Shares of the telehealth services provider have appreciated by 16.85% over the course of the past month, outperforming the Medical sector's gain of 6.06%, and the S&P 500's gain of 0.55%.
Analysts and investors alike will be keeping a close eye on the performance of Teladoc in its upcoming earnings disclosure. The company's earnings report is set to go public on July 29, 2026. The company is predicted to post an EPS of -$0.24, indicating a 26.32% decline compared to the equivalent quarter last year. Simultaneously, our latest consensus estimate expects the revenue to be $614.69 million, showing a 2.72% drop compared to the year-ago quarter.
For the annual period, the Zacks Consensus Estimates anticipate earnings of -$0.92 per share and a revenue of $2.51 billion, signifying shifts of +19.3% and -0.92%, respectively, from the last year.
Any recent changes to analyst estimates for Teladoc should also be noted by investors. These revisions typically reflect the latest short-term business trends, which can change frequently. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has remained steady. Currently, Teladoc is carrying a Zacks Rank of #2 (Buy).
The Medical Services industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 95, positioning it in the top 39% of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Class A or Class C common stock of Zillow Group, Inc. (NASDAQ: ZG) (NASDAQ: Z) between February 11, 2025 and May 7, 2026, both dates inclusive (the "Class Period"), of the important August 10, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.
So what: If you purchased Zillow common stock during the Class Period, you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
What to do next: To join the Zillow class action, go to https://rosenlegal.com/cases/zillow-group-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 10, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
Details of the case: According to the lawsuit, defendants throughout the Class Period made materially false and/or misleading statements and/or failed to disclose that: (1) Zillow's agreement with Redfin Corporation was not a "partnership," but rather an acquisition of Redfin's business; (2) as a result of the Redfin Agreement, Zillow faced a materially heightened risk of regulatory scrutiny and liability under federal antitrust laws; (3) upon the filing of an antitrust lawsuit, Zillow continued to downplay its legal exposure; and (4) as a result, defendants' statements about Zillow's business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the Zillow class action, go to https://rosenlegal.com/cases/zillow-group-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com
Yanjun Wang, CCO and GC of Sea Limited (SE +1.58%), sold 2,700 Class A ordinary shares through an indirect entity on July 16 and 17, 2026, according to a recent SEC Form 4 filing.
Transaction summaryMetricValueTransaction value$286,335Shares sold (indirectly held)2,700Post-transaction shares (directly held)~1,162,000Post-transaction shares (indirectly held)31,300Post-transaction value$124.21 millionTransaction value based on SEC Form 4 weighted average sale price ($106.05); post-transaction value based on July 17, 2026 market close ($104.05).
Key questionsWhat was the mechanism behind this disposition?
The sale was conducted pursuant to a Rule 10b5-1 trading plan adopted by a BVI entity controlled by the reporting person on March 26, 2026, which allows insiders to schedule trades in advance to avoid concerns regarding material non-public information.How does this impact the executive's total exposure to the company?
While the sale liquidated 8% of the indirect holdings held via the BVI entity, the total stake remains substantial as the executive continues to hold about 1.2 million shares directly.What is the recent performance context for the company's equity?
As of the final transaction date on July 17, 2026, Sea Limited shares had a one-year return of (38%), a period during which the company maintained a market capitalization of $62.5 billion.What are the core business drivers for the firm?
Based in Singapore, Sea Limited operates across Southeast Asia and Latin America, focusing on digital entertainment through its Garena platform, e-commerce, and digital financial services.Company OverviewMetricValueShare Price (as of market close 2026-07-17)$104.05Market Capitalization$62.5 billionRevenue (TTM)$25.2 billionNet Income (TTM)$1.6 billionCompany SnapshotSea Limited operates a diversified digital platform ecosystem spanning digital entertainment through its Garena brand, e-commerce operations, and digital financial services across Southeast Asia, Latin America, and other international markets.The company generates revenue through multiple channels including in-game monetization and eSports events within its digital entertainment segment, transaction fees and marketplace commissions from e-commerce operations, and financial services offerings including digital payments and lending solutions.Sea Limited serves a broad consumer base across emerging markets in Southeast Asia and Latin America, targeting mobile and PC gamers, online shoppers, and consumers seeking digital financial services in regions with high growth potential and expanding digital adoption.Sea Limited is a leading digital platform operator with significant scale, commanding a $62.5 billion market capitalization and generating $25.2 billion in TTM revenue across its integrated ecosystem. The company's competitive advantage derives from its diversified business model that leverages network effects across gaming, commerce, and fintech segments, combined with deep market penetration in high-growth emerging markets where digital adoption continues to accelerate. Sea Limited has established itself as a critical infrastructure provider in digital commerce and entertainment across Southeast Asia and Latin America.
What this transaction means for investorsWang has been clipping shares off the same BVI entity in shrinking batches, 3,000 in mid-July, now 2,700, at steadily lower prices as the stock slid from the $112 range to $106. That's what a plan running on a fixed schedule looks like when the market moves against it. She set the arrangement in March, months before these prices existed, and her direct holding of roughly 1.2 million shares hasn't budged through any of it.
The disconnect between that share price and the underlying business is the real story. Sea's first-quarter revenue climbed 47% to $7.1 billion, adjusted EBITDA cleared $1 billion, and Shopee moved a record $37.3 billion in merchandise. CEO Forrest Li called 2026 a year of "leaning in to deepen our competitive moats" with financial discipline. Still, the stock is down 38% amid growing e-commerce competition, but with revenue growing at its current pace, the stock could be poised for a turnaround, and for what it’s worth, shares have climbed about 30% from a March trough.
Jonathan Ponciano has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Sea Limited. The Motley Fool has a disclosure policy.
Gang Ye, the COO of Sea Limited (SE +1.58%), reported the sale of 40,000 Class A ordinary shares for approximately $4.2 million in an indirect transaction, according to an SEC Form 4 filing.
Transaction summaryMetricValueTransaction value$4.2 millionShares sold40,000Post-transaction shares (directly held)21,636,405Post-transaction shares (indirectly held)320,000Post-transaction value$2.28 billionTransaction value based on SEC Form 4 weighted average sale price ($105.61); post-transaction value based on July 17, 2026 market close ($104.05).
Key questionsWhat was the structural nature of this transaction?
This was an indirect sale executed through a British Virgin Islands entity controlled by Ye. The activity was non-discretionary, occurring under a Rule 10b5-1 trading plan established in late 2025 to manage equity holdings through a systematic schedule.How significant was the reduction in the insider's equity position?
The 40,000-share sale had a minimal impact on the insider's total exposure, reducing the overall stake by 0.2%. The vast majority of the insider's equity remains held directly, totaling over 21.6 million shares following the transaction.What is the company's current market profile?
Sea Limited is a Singapore-based firm operating in digital entertainment, e-commerce, and digital financial services with a market capitalization of $62.5 billion as of July 17, 2026. Company OverviewMetricValueShare Price (as of market close 2026-07-17)$104.05Market Capitalization$62.5 billionRevenue (TTM)$25.2 billionNet Income (TTM)$1.6 billionCompany SnapshotSea Limited operates a diversified digital platform ecosystem spanning digital entertainment through its Garena brand, e-commerce operations, and digital financial services across Southeast Asia, Latin America, and other international markets.The company generates revenue through multiple channels including in-game monetization and eSports events within its digital entertainment segment, transaction fees and marketplace commissions from e-commerce operations, and financial services offerings including digital payments and lending solutions.Sea Limited serves a broad consumer base across emerging markets in Southeast Asia and Latin America, targeting mobile and PC gamers, online shoppers, and consumers seeking digital financial services in regions with high growth potential and expanding digital adoption.Sea Limited is a leading digital platform operator with significant scale, commanding a $62.5 billion market capitalization and generating $25.2 billion in TTM revenue across its integrated ecosystem. The company's competitive advantage derives from its diversified business model that leverages network effects across gaming, commerce, and fintech segments, combined with deep market penetration in high-growth emerging markets where digital adoption continues to accelerate. Sea Limited has established itself as a critical infrastructure provider in digital commerce and entertainment across Southeast Asia and Latin America.
What this transaction means for investorsYe's BVI entity is working through a schedule set late last year, and the falling execution prices are just what the market handed it. The Sea co-founder's direct stake of more than 21.6 million shares, worth over $2.2 billion, hasn't moved through either sale, and trimming 0.2% of a position that size is a bookkeeping exercise for a billionaire. In other words, this isn’t something long-term investors should read too deeply into without any accelerated pace of selling.
The stock, meanwhile, has clawed back about 30% from its March low and still sits far below where it started the year. That gap is peculiar against the firm’s latest results: First-quarter revenue rose 47% to $7.1 billion as adjusted EBITDA topped $1 billion, and Shopee handled a record $37.3 billion in merchandise. The recovery off the March bottom will be important to watch. If the business keeps compounding at these rates, the rebound has room to run. If growth cools, however, a stock this far off its highs could find lower lows.
Jonathan Ponciano has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Sea Limited. The Motley Fool has a disclosure policy.
Tianyu Hou, CFO, sold 15,000 Class A ordinary shares of Sea Limited (SE +1.58%) on July 17, 2026, according to a recent SEC Form 4 filing.
Transaction summaryMetricValueTransaction value$1.5 millionShares sold15,000Post-transaction shares (directly held)2,428,015Post-transaction value$252.63 millionTransaction value based on SEC Form 4 weighted average sale price ($103.26); post-transaction value based on July 17, 2026 market close ($104.05).
Key questionsWhat was the mechanism for this transaction?
The sale was conducted through a Rule 10b5-1 trading plan adopted on March 19, 2026, which allows corporate insiders to sell a predetermined number of shares at set times to manage personal portfolios.What is the scale of the insider's remaining equity?
Following the sale, Tianyu Hou continues to hold 2,428,015 shares directly, representing a total equity position valued at $252.63 million based on the July 17, 2026 market close.How does the transaction price compare to recent performance?
The shares were sold at $103.26 per share, occurring as the stock's one-year return reached -38% as of the July 17, 2026 transaction date.Which entities were involved in the ownership change?
The 15,000 shares sold were held through a BVI entity controlled by Tianyu Hou, while all remaining reported shares are held in the insider's direct name.Company OverviewMetricValueShare Price (as of market close 2026-07-17)$104.05Market Capitalization$62.5 billionRevenue (TTM)$25.2 billionNet Income (TTM)$1.6 billionCompany SnapshotSea Limited operates a diversified digital platform ecosystem spanning digital entertainment through its Garena brand, e-commerce operations, and digital financial services across Southeast Asia, Latin America, and other international markets.The company generates revenue through multiple channels including in-game monetization and eSports events within its digital entertainment segment, transaction fees and marketplace commissions from e-commerce operations, and financial services offerings including digital payments and lending solutions.Sea Limited serves a broad consumer base across emerging markets in Southeast Asia and Latin America, targeting mobile and PC gamers, online shoppers, and consumers seeking digital financial services in regions with high growth potential and expanding digital adoption.Sea Limited is a leading digital platform operator with significant scale, commanding a $62.5 billion market capitalization and generating $25.2 billion in TTM revenue across its integrated ecosystem. The company's competitive advantage derives from its diversified business model that leverages network effects across gaming, commerce, and fintech segments, combined with deep market penetration in high-growth emerging markets where digital adoption continues to accelerate. Sea Limited has established itself as a critical infrastructure provider in digital commerce and entertainment across Southeast Asia and Latin America.
What this transaction means for investorsAmid a slew of trading plan-driven Sea Limited stock sales this past week, it’s important to note here that Hou is the finance chief, the executive with the clearest view of the books, which makes what he kept more telling than what he sold. His direct position of over 2.4 million shares, worth roughly $253 million, is virtually untouched: He sold just six-tenths of a percent of it.
Meanwhile, the numbers he oversees have been strong, even if the stock has been intensely volatile amid broader uncertainty around e-commerce competition, with first-quarter revenue climbing 47% to $7.1 billion and adjusted EBITDA passing $1 billion. In the firm’s earnings report, CEO Forrest Li noted that the firm is starting to see improved unit economics thanks to strategic investments that have also boosted topline growth. Whether these metrics meaningfully improve and continue will likely determine how Sea’s stock moves forward in the coming quarters.
Jonathan Ponciano has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Sea Limited. The Motley Fool has a disclosure policy.
SummaryOil prices could climb above $115-$120 should flows be disrupted, consultant saysSaudi crude shipments to Asia could face longer routesAsian refiners could face delays of around a month for Yanbu cargoes, Kpler analyst saysLONDON/HOUSTON, July 20 (Reuters) - A successful effort by Yemen's Houthis to shut the Bab el-Mandeb Strait would strike at one of the world's most important oil shipping routes, potentially triggering a fresh surge in crude prices, disrupting fuel supplies and adding to strains on the global economy.
Yemen's Iran-aligned Houthis on Monday declared a naval blockade against Saudi Arabia, its military spokesperson said. A closure of the Red Sea's southern gateway would remove a critical alternative route for the kingdom to the Strait of Hormuz and intensify fears of shortages.
The Reuters Power Up newsletter provides everything you need to know about the global energy industry. Sign up here.
"After oil prices moved higher on escalating U.S.-Iran tensions last week and the resulting slowdown in Hormuz transits, traders are watching for catalysts that would justify a further rally," said Richard Bronze of consultancy Energy Aspects.
"The Houthis resuming maritime attacks and effectively shutting the Bab el-Mandeb would certainly qualify."
Oil rose less than 1% after the Houthi statement to trade around $89 a barrel . Hopes of Iran and the United States resuming peace talks had earlier weighed on prices. Oil futures have peaked at $126 this year - below 2008's all-time high of $147.
ASIAN REFINERS WOULD FACE DELAYS IN GETTING CRUDEThe Bab el-Mandeb connects the Red Sea with the Gulf of Aden and is a key route for crude and fuel shipments moving between the Middle East, Europe and Asia. Since Houthi attacks on shipping began in 2023, many vessels have already rerouted around Africa, adding costs and delays to global trade.
Item 1 of 3 Boats float near the coast of Bab el-Mandeb, Yemen April 2, 2026. REUTERS/File Photo
[1/3]Boats float near the coast of Bab el-Mandeb, Yemen April 2, 2026. REUTERS/File Photo Purchase Licensing Rights, opens new tab
A full closure would have the biggest immediate impact on Saudi crude exports from the Red Sea port of Yanbu. Matt Smith, commodity research director at Kpler, said Asian refiners receiving those barrels could face delays of around a month as tankers are forced to sail around the Cape of Good Hope.
"The impact is going to be massive in the first month," Smith said. "The biggest impact is going to be on Saudi flows."
Bronze estimated that more than 3 million barrels per day of Saudi crude currently shipped via the Red Sea to Asia could be forced onto much longer routes. The disruption would create logistical bottlenecks because fully loaded VLCCs cannot transit the Suez Canal while capacity on Egypt's SUMED pipeline, which links the Red Sea and Mediterranean Sea, is fixed.
Saudi Arabia has shipped on average over 4.5 million bpd of crude and fuel from Yanbu since April, about 70% of which went to Asia, Kpler data shows.
The impact would extend far beyond oil markets, said John Paisie, president of consultancy Stratas Advisors.
"If they really stop and severely hinder those barrels through the Red Sea, that is going to have an impact on oil prices as well as refined product prices," he said. "It undermines the whole global economy. At some point, you could have a global recession.”
The immediate oil market reaction would likely be another jump in crude prices as refiners compete for available supplies, analysts said. Paisie said oil prices could climb back above $115-$120 a barrel, while freight and insurance costs would also rise as ships take longer routes around Africa.
European diesel refining margins surged to a record above $65 a barrel on Friday and remained near that level on Monday. Supplies of diesel and jet fuel from Asia and the Middle East to Europe typically transit the Bab el-Mandeb.
Reporting by Ahmad Ghaddar and Robert Harvey in London, and Arathy Somasekhar in Houston, editing by Alex Lawler and Sanjeev Miglani
Our Standards: The Thomson Reuters Trust Principles., opens new tab
Eli Lilly (LLY - Free Report) ended the recent trading session at $1,146.90, demonstrating a -2.73% change from the preceding day's closing price. This move lagged the S&P 500's daily loss of 0.19%. Meanwhile, the Dow lost 0.59%, and the Nasdaq, a tech-heavy index, lost 0.05%.
The stock of drugmaker has risen by 7.33% in the past month, leading the Medical sector's gain of 6.06% and the S&P 500's gain of 0.55%.
The investment community will be closely monitoring the performance of Eli Lilly in its forthcoming earnings report. The company is scheduled to release its earnings on August 5, 2026. In that report, analysts expect Eli Lilly to post earnings of $7.47 per share. This would mark year-over-year growth of 18.38%. In the meantime, our current consensus estimate forecasts the revenue to be $20.26 billion, indicating a 30.24% growth compared to the corresponding quarter of the prior year.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $34.55 per share and revenue of $85.78 billion. These totals would mark changes of +42.71% and +31.6%, respectively, from last year.
Investors might also notice recent changes to analyst estimates for Eli Lilly. These revisions help to show the ever-changing nature of near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 3.52% lower. At present, Eli Lilly boasts a Zacks Rank of #3 (Hold).
From a valuation perspective, Eli Lilly is currently exchanging hands at a Forward P/E ratio of 34.13. This indicates a premium in contrast to its industry's Forward P/E of 16.49.
We can additionally observe that LLY currently boasts a PEG ratio of 1.48. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. As of the close of trade yesterday, the Large Cap Pharmaceuticals industry held an average PEG ratio of 2.65.
The Large Cap Pharmaceuticals industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 231, positioning it in the bottom 7% of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.
4:20pm: Early rally fades US stocks finished mixed on Monday as an early rally lost steam, with investors taking some profits in semiconductor stocks ahead of a pivotal week of Big Tech earnings while keeping a close eye on another jump in oil prices.
The Dow Jones Industrial Average led the declines, falling 307 points, or 0.6%, to close at 51,839. The S&P 500 slipped 14 points, or 0.2%, to 7,443, while the Nasdaq managed to hold near the flatline, edging down just 12 points, or 0.05%, to 25,508.
Chipmakers, which helped fuel the market's recent advance, gave back much of their earlier gains as traders turned cautious before earnings from technology heavyweights later this week. Results from Tesla and Alphabet are expected to set the tone for the broader sector, with investors looking for signs that spending on artificial intelligence remains strong.
Oil prices also stayed in focus after briefly climbing above US$90 a barrel during the session before pulling back, adding another layer of uncertainty for markets already weighing the outlook for inflation and interest rates.
Attention now shifts to another busy day of corporate earnings on Tuesday, with reports due before the opening bell from industrial giant 3M, automaker General Motors, financial services firm Charles Schwab and oilfield services company Halliburton.
3:45pm: Proactive news headlines Replenish Nutrients Holding Corp (CSE:ERTH, OTC:VVIVF, FRA:7KE) secured a $15 million strategic investment from SRC Agrominerals to expand its Beiseker fertilizer facility and secure a long-term supply of carbonatite for its regenerative fertilizer products. VivoPower PLC (NASDAQ:VIVO, FRA:51J) appointed Syed Muhammad Nouman as Group Finance Director, with additional responsibilities as its Principal Financial Officer and Principal Accounting Officer for SEC reporting. Thistle Resources (TSX-V:TRCG, OTC:TRCGF) has launched its 2026 trenching program at the Brunswick antimony project in New Brunswick to further define mineralization across key target areas. Varon Corp (OTCID:OZSC) said its BALLISLIFE Drink joint venture served as the presenting hydration partner for Ballislife's inaugural 1v1 Championship in Las Vegas, expanding the brand's presence through live basketball events. EDM Resources Inc (TSX-V:EDM, OTC:SWNLF) received amended environmental approval for its Scotia Mine in Nova Scotia, allowing the company to move forward with its updated mine plan and processing facility ahead of a planned restart. OKYO Pharma Ltd (NASDAQ:OKYO) filed its annual report for fiscal 2026, highlighting its financial position and progress toward a planned Phase 3 trial of its lead drug candidate. 2:40pm: Market movers Hut 8 Mining Corp (TSX:HUT) shares jumped nearly 12% after the company signed a 15-year lease for 352 MW at its Beacon Point AI data center campus, fully commercializing the 1-gigawatt Texas facility and lifting its contracted portfolio. Tempus AI agreed to acquire Personalis in a $1.5 billion all-stock deal, strengthening its position in cancer recurrence testing by offering Personalis shareholders $16.25 per share. AMC Entertainment Holdings (NYSE:AMC) shares gained 11% after the theater chain posted better-than-expected second-quarter results, fueled by strong demand for summer blockbuster films. Replenish Nutrients Holding Corp (CSE:ERTH, OTC:VVIVF, FRA:7KE) secured a $15 million strategic investment from SRC Agrominerals to expand its Beiseker fertilizer facility and secure a long-term supply of carbonatite for its regenerative fertilizer products. Domino's Pizza Inc (NYSE:DPZ) shares rose about 3% after the company reported second-quarter revenue that beat expectations, despite earnings coming in below forecasts, as order growth and global store expansion remained strong. 1:25pm: Market breadth improves Market breadth continues to improve, even if it has pulled back lately, according to Adam Turnquist, Chief Technical Strategist for LPL Financial.
"The percentage of S&P 500 constituents trading above their 200-day moving average has increased from the low-50% range in May to nearly 70%, signaling that participation beneath the surface remains considerably healthier than it was just a few months ago," Turnquist noted.
"A decisive move back above 7,578 would put the 7,600 milestone, the closing high of 7,610, and the intraday high of 7,621 back into focus."
12:10pm: Fresh attacks rattle markets Further US strikes against Iran are keeping markets on edge, according to Chris Beauchamp, Chief Market Analyst at online trading and investing platform IG.
“The tone for the week has already been set as the US and Iran continue to trade strikes. And now a second waterway closure looms to cause further problems for global markets," Beauchamp commented.
"While some hints of a return to negotiations helped to continue Friday’s late rally, this has begun to stumble as news of fresh attacks filters through. The next two weeks will be a tussle between conflict news and big-name earnings, and the tug of war between these two is likely to keep volatility elevated.”
11:05am: Week ahead Wall Street heads into a pivotal week with investors preparing for a flood of corporate earnings, major artificial intelligence announcements and lingering geopolitical tensions that have pushed oil prices above $90 a barrel.
The spotlight will be on Wednesday's earnings from Alphabet Inc (NASDAQ:GOOG) (Alphabet Inc (NASDAQ:GOOG)) and Tesla Inc (NASDAQ:TSLA) (Tesla Inc (NASDAQ:TSLA)), which many see as a crucial test for the AI-driven rally after last week's sharp selloff in technology stocks.
More than 70 S&P 500 companies are due to report over the coming days, including Texas Instruments Inc (NASDAQ:TXN) (Texas Instruments Inc (NASDAQ:TXN)), International Business Machines Corp (NYSE:IBM) (International Business Machines Corp (NYSE:IBM)), AT&T Inc (NYSE:T, XETRA:SOBA) (AT&T Inc (NYSE:T, XETRA:SOBA), AT&T Inc (NYSE:T, XETRA:SOBA)) on Wednesday, Intel Corp (NASDAQ:INTC, XETRA:INL) (Intel Corp (NASDAQ:INTC, XETRA:INL), Intel Corp (NASDAQ:INTC, XETRA:INL)), T-Mobile US Inc (NASDAQ:TMUS, XETRA:TM5) (T-Mobile US Inc (NASDAQ:TMUS, XETRA:TM5), T-Mobile US Inc (NASDAQ:TMUS, XETRA:TM5)), Lockheed Martin and Comcast on Thursday, and American Express and Verizon on Friday. Earlier in the week, General Motors, Charles Schwab, Capital One and Danaher will also release results.
Tesla will also be closely watched after reporting record second-quarter vehicle deliveries, with investors looking for updates on cash flow, margins and any news surrounding its autonomous vehicle plans.
10:00am: Semiconductors lift Nasdaq Stocks opened higher on Monday, with technology shares leading the way as investors looked ahead to a busy week of corporate earnings from some of the market's biggest names.
Shortly after the opening bell, the Nasdaq was up 282 points, or 1.1%, to 25,802. The S&P 500 gained 53 points, or 0.7%, to 7,511, while the Dow Jones added 154 points, or 0.3%, to 52,300.
Semiconductor stocks helped power the early gains as traders positioned themselves ahead of quarterly results from several major technology companies. The second-quarter earnings season shifts into a higher gear this week, with Tesla, Alphabet and IBM scheduled to report on Wednesday, followed by Intel on Thursday.
Energy markets also remained in focus. Brent crude climbed back above US$90 a barrel as fighting between the United States and Iran continued, although prices eased from their highs after Iran's foreign ministry said diplomatic efforts were still underway.
On the corporate front, Domino's Pizza was among the early winners after the company released quarterly earnings before the market opened.
Investors will also be watching fresh economic data, with the June US Leading Economic Index due later this morning, for further clues about the strength of the economy.
7:45am: Big week of earnings US stock futures pointed higher on Monday as attention turned to a bumper week of Big Tech earnings, even with the US-Iran conflict grinding into its tenth day.
Dow futures edged up 0.2%, S&P 500 contracts added 0.3%, and the Nasdaq-100 popped 0.7%, a welcome bounce after a bruising week for semiconductor stocks.
The AI trade is hunting for its next catalyst, and it may well arrive this week with results due from Alphabet, Tesla, Intel and IBM.
Wall Street has raised the bar for all four, with investors wanting proof that the vast sums being poured into AI infrastructure are actually starting to generate revenue.
The mood was helped by oil pulling back from its highs.
Brent briefly crossed $91 a barrel overnight before retreating to around $86.70, down 1.6%, after Iran signalled that diplomatic channels with Washington remain open via mediators in Pakistan and Qatar.
That said, the conflict itself shows little sign of easing, with US airstrikes continuing and Iranian retaliation killing at least three American service members over the weekend.
Traffic through the Strait of Hormuz hit a three-week low on Friday, and US gasoline prices crossed $4 a gallon again, an unwelcome development three months out from the midterms.
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Intuit Inc. (NASDAQ: INTU) between August 22, 2025 and May 20, 2026, inclusive (the “Class Period”), of the important September 8, 2026 lead plaintiff deadline.
SO WHAT: If you purchased Intuit securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Intuit class action, go to https://rosenlegal.com/cases/intuit-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 8, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made materially false and misleading statements and/or failed to disclose that: (1) they had overstated Intuit’s competitive advantages and growth, as well as the overall strength and sustainability of its business model and operations; (2) in reality, Intuit was losing significant business in its tax-related business, particularly in its Turbo Tax business, as a result of, inter alia, increasing competitive and pricing pressures; (3) accordingly, Intuit’s previously issued full year (“FY”) 2026 TurboTax revenue growth guidance was unreliable and/or unrealistic; and (4) as a result, defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the Intuit class action, go to https://rosenlegal.com/cases/intuit-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827 [email protected]
www.rosenlegal.com
Broadcom Inc. (AVGO - Free Report) closed the most recent trading day at $378.16, moving +1.98% from the previous trading session. The stock outpaced the S&P 500's daily loss of 0.19%. Elsewhere, the Dow saw a downswing of 0.59%, while the tech-heavy Nasdaq depreciated by 0.05%.
Shares of the chipmaker witnessed a loss of 9.85% over the previous month, trailing the performance of the Computer and Technology sector with its loss of 4.32%, and the S&P 500's gain of 0.55%.
The investment community will be paying close attention to the earnings performance of Broadcom Inc. in its upcoming release. On that day, Broadcom Inc. is projected to report earnings of $3.22 per share, which would represent year-over-year growth of 90.53%. Meanwhile, our latest consensus estimate is calling for revenue of $29.46 billion, up 84.69% from the prior-year quarter.
For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of $11.73 per share and a revenue of $106.05 billion, representing changes of +71.99% and +65.99%, respectively, from the prior year.
Investors should also pay attention to any latest changes in analyst estimates for Broadcom Inc. Such recent modifications usually signify the changing landscape of near-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 0.01% higher within the past month. As of now, Broadcom Inc. holds a Zacks Rank of #2 (Buy).
Digging into valuation, Broadcom Inc. currently has a Forward P/E ratio of 31.61. This valuation marks a discount compared to its industry average Forward P/E of 43.65.
Meanwhile, AVGO's PEG ratio is currently 0.57. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. AVGO's industry had an average PEG ratio of 1.69 as of yesterday's close.
The Electronics - Semiconductors industry is part of the Computer and Technology sector. Currently, this industry holds a Zacks Industry Rank of 40, positioning it in the top 17% of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
In the latest trading session, Pan American Silver (PAAS - Free Report) closed at $42.19, marking a +1.01% move from the previous day. The stock exceeded the S&P 500, which registered a loss of 0.19% for the day. At the same time, the Dow lost 0.59%, and the tech-heavy Nasdaq lost 0.05%.
The stock of silver mining company has fallen by 14.76% in the past month, lagging the Basic Materials sector's loss of 9.42% and the S&P 500's gain of 0.55%.
Analysts and investors alike will be keeping a close eye on the performance of Pan American Silver in its upcoming earnings disclosure. The company's earnings report is set to go public on August 12, 2026. The company's upcoming EPS is projected at $0.93, signifying a 116.28% increase compared to the same quarter of the previous year. At the same time, our most recent consensus estimate is projecting a revenue of $1.21 billion, reflecting a 48.47% rise from the equivalent quarter last year.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $4.02 per share and revenue of $4.92 billion. These totals would mark changes of +58.27% and +36.09%, respectively, from last year.
Any recent changes to analyst estimates for Pan American Silver should also be noted by investors. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the past month, there's been a 13.47% fall in the Zacks Consensus EPS estimate. Currently, Pan American Silver is carrying a Zacks Rank of #5 (Strong Sell).
In the context of valuation, Pan American Silver is at present trading with a Forward P/E ratio of 10.39. This indicates no noticeable deviation in contrast to its industry's Forward P/E of 10.39.
It is also worth noting that PAAS currently has a PEG ratio of 3.89. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. The Mining - Silver industry currently had an average PEG ratio of 3.89 as of yesterday's close.
The Mining - Silver industry is part of the Basic Materials sector. At present, this industry carries a Zacks Industry Rank of 102, placing it within the top 42% of over 250 industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.
In the latest trading session, Coinbase Global, Inc. (COIN - Free Report) closed at $160.43, marking a +2.11% move from the previous day. This move outpaced the S&P 500's daily loss of 0.19%. Elsewhere, the Dow saw a downswing of 0.59%, while the tech-heavy Nasdaq depreciated by 0.05%.
Prior to today's trading, shares of the company had lost 3.76% lagged the Finance sector's gain of 2.54% and the S&P 500's gain of 0.55%.
The investment community will be paying close attention to the earnings performance of Coinbase Global, Inc. in its upcoming release. The company is slated to reveal its earnings on July 30, 2026. The company is forecasted to report an EPS of $0.19, showcasing a 58.33% upward movement from the corresponding quarter of the prior year. Our most recent consensus estimate is calling for quarterly revenue of $1.32 billion, down 11.83% from the year-ago period.
For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of $1.41 per share and a revenue of $5.88 billion, representing changes of -65.01% and -18.11%, respectively, from the prior year.
Investors should also note any recent changes to analyst estimates for Coinbase Global, Inc. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 18.8% lower within the past month. Currently, Coinbase Global, Inc. is carrying a Zacks Rank of #4 (Sell).
Valuation is also important, so investors should note that Coinbase Global, Inc. has a Forward P/E ratio of 111.3 right now. This expresses a premium compared to the average Forward P/E of 10.79 of its industry.
It's also important to note that COIN currently trades at a PEG ratio of 10.14. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. The Financial - Miscellaneous Services was holding an average PEG ratio of 0.93 at yesterday's closing price.
The Financial - Miscellaneous Services industry is part of the Finance sector. This industry, currently bearing a Zacks Industry Rank of 176, finds itself in the bottom 29% echelons of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.
In the latest trading session, Palo Alto Networks (PANW - Free Report) closed at $348.66, marking a -2.79% move from the previous day. This change lagged the S&P 500's 0.19% loss on the day. Meanwhile, the Dow experienced a drop of 0.59%, and the technology-dominated Nasdaq saw a decrease of 0.05%.
Heading into today, shares of the security software maker had gained 24.64% over the past month, outpacing the Computer and Technology sector's loss of 4.32% and the S&P 500's gain of 0.55%.
Market participants will be closely following the financial results of Palo Alto Networks in its upcoming release. The company is expected to report EPS of $0.97, up 2.11% from the prior-year quarter. Simultaneously, our latest consensus estimate expects the revenue to be $3.35 billion, showing a 32.1% escalation compared to the year-ago quarter.
PANW's full-year Zacks Consensus Estimates are calling for earnings of $3.77 per share and revenue of $11.41 billion. These results would represent year-over-year changes of +12.87% and +23.71%, respectively.
Investors might also notice recent changes to analyst estimates for Palo Alto Networks. These latest adjustments often mirror the shifting dynamics of short-term business patterns. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. Palo Alto Networks presently features a Zacks Rank of #3 (Hold).
Looking at valuation, Palo Alto Networks is presently trading at a Forward P/E ratio of 95.14. Its industry sports an average Forward P/E of 51.25, so one might conclude that Palo Alto Networks is trading at a premium comparatively.
One should further note that PANW currently holds a PEG ratio of 7.17. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. The Security industry currently had an average PEG ratio of 3.27 as of yesterday's close.
The Security industry is part of the Computer and Technology sector. At present, this industry carries a Zacks Industry Rank of 47, placing it within the top 20% of over 250 industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.
Spotify (SPOT - Free Report) closed at $492.32 in the latest trading session, marking a +2.97% move from the prior day. This move outpaced the S&P 500's daily loss of 0.19%. Elsewhere, the Dow lost 0.59%, while the tech-heavy Nasdaq lost 0.05%.
Shares of the music-streaming service operator witnessed a gain of 2.15% over the previous month, beating the performance of the Computer and Technology sector with its loss of 4.32%, and the S&P 500's gain of 0.55%.
Investors will be eagerly watching for the performance of Spotify in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on August 4, 2026. In that report, analysts expect Spotify to post earnings of $3.28 per share. This would mark year-over-year growth of 783.33%. Alongside, our most recent consensus estimate is anticipating revenue of $5.58 billion, indicating a 17.27% upward movement from the same quarter last year.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $14.51 per share and revenue of $22.62 billion. These totals would mark changes of +22.04% and +16.41%, respectively, from last year.
Investors should also pay attention to any latest changes in analyst estimates for Spotify. These revisions help to show the ever-changing nature of near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 1.15% lower. Spotify is holding a Zacks Rank of #4 (Sell) right now.
Looking at its valuation, Spotify is holding a Forward P/E ratio of 32.95. This denotes a premium relative to the industry average Forward P/E of 20.12.
We can additionally observe that SPOT currently boasts a PEG ratio of 1.18. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. By the end of yesterday's trading, the Internet - Software industry had an average PEG ratio of 1.09.
The Internet - Software industry is part of the Computer and Technology sector. This industry, currently bearing a Zacks Industry Rank of 91, finds itself in the top 37% echelons of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow SPOT in the coming trading sessions, be sure to utilize Zacks.com.
AGNC Investment (AGNC - Free Report) came out with quarterly earnings of $0.4 per share, beating the Zacks Consensus Estimate of $0.38 per share. This compares to earnings of $0.38 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +5.26%. A quarter ago, it was expected that this real estate investment trust would post earnings of $0.36 per share when it actually produced earnings of $0.42, delivering a surprise of +16.67%.
Over the last four quarters, the company has surpassed consensus EPS estimates two times.
AGNC Investment, which belongs to the Zacks REIT and Equity Trust industry, posted revenues of $305 million for the quarter ended June 2026, missing the Zacks Consensus Estimate by 16.31%. This compares to year-ago revenues of $162 million. The company has not been able to beat consensus revenue estimates over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
AGNC Investment shares have added about 4.7% since the beginning of the year versus the S&P 500's gain of 8.9%.
What's Next for AGNC Investment?While AGNC Investment has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for AGNC Investment was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.39 on $385.84 million in revenues for the coming quarter and $1.57 on $1.47 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, REIT and Equity Trust is currently in the bottom 19% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Another stock from the same industry, Armour Residential REIT (ARR - Free Report) , has yet to report results for the quarter ended June 2026.
This real estate investment trust is expected to post quarterly earnings of $0.69 per share in its upcoming report, which represents a year-over-year change of -10.4%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
Armour Residential REIT's revenues are expected to be $59.2 million, up 78.9% from the year-ago quarter.
South Korea’s decision to fine American-owned eCommerce firm Coupang is straining relations between the two countries, Reuters reported Friday (July 20).
South Korea said the fine was imposed over a data leak, but American lawmakers said the move raises questions about whether the country is treating U.S. companies fairly, according to the report.
The fine of 625 billion won (about $422 million) followed Coupang’s November 2025 data leak, per the report.
The dispute over the fine has become serious enough that South Korea’s ambassador to the U.S. returned to Seoul to discuss it with officials in President Lee Jae Myung’s administration, the report said.
The ambassador, Kang Kyung-wha, told local media, per the report: “The issue is dragging on much longer than I expected.”
A lawmaker who is a member of South Korea’s ruling Democratic Party, Park Sun-won, said in the report that the fine imposed on Coupang was for the data leak and that the fine “would be the same for any company.”
A U.S. State Department spokesperson said in the report that South Korea “should not impose disproportionate burdens on U.S. companies.”
Coupang told Reuters that the company hopes to find a constructive resolution.
It was reported in November 2025 that Coupang is considered the “Amazon of South Korea” and that the data breach exposed personal information of the company’s entire customer base. The exposed data was limited to customers’ names, email addresses, phone numbers, shipping addresses and some order histories.
In December 2025, it was reported that an investor class action lawsuit filed in California alleged that Coupang violated securities laws after the data breach by misleading investors about its data security practices and failing to disclose the breach in a timely manner.
Coupang announced in December 2025 that the perpetrator of the data breach, a former Coupang employees, retained data from only 3,000 accounts, did not transfer the data to others, and later deleted the data when news outlets began reporting the incident.
Days later, on Dec. 29, Coupang issued an apology from the company’s interim CEO and said it would begin offering vouchers worth up to 55,000 won ($38) to each of the 33.7 million customers affected by the cybersecurity incident.
In January, it was reported that two Coupang investors called on the U.S. government to investigate South Korea’s handling of the incident and said the U.S. could also impose trade remedies in response to what they said was discriminatory treatment of Coupang.
When South Korea’s Personal Information Protection Commission levied the roughly $412 million fine on Coupang in June, it was reported that the fine was the largest ever imposed for a privacy violation in South Korea.
In the latest close session, SLB (SLB - Free Report) was down 1.28% at $46.39. The stock's performance was behind the S&P 500's daily loss of 0.19%. Elsewhere, the Dow lost 0.59%, while the tech-heavy Nasdaq lost 0.05%.
The world's largest oilfield services company's stock has dropped by 2.29% in the past month, falling short of the Business Services sector's gain of 4.14% and the S&P 500's gain of 0.55%.
The investment community will be paying close attention to the earnings performance of SLB in its upcoming release. The company is slated to reveal its earnings on July 24, 2026. It is anticipated that the company will report an EPS of $0.51, marking a 31.08% fall compared to the same quarter of the previous year. Our most recent consensus estimate is calling for quarterly revenue of $8.71 billion, up 1.92% from the year-ago period.
For the full year, the Zacks Consensus Estimates are projecting earnings of $2.53 per share and revenue of $36.51 billion, which would represent changes of -13.65% and +2.24%, respectively, from the prior year.
Any recent changes to analyst estimates for SLB should also be noted by investors. These recent revisions tend to reflect the evolving nature of short-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 3.13% lower. SLB presently features a Zacks Rank of #4 (Sell).
In terms of valuation, SLB is presently being traded at a Forward P/E ratio of 18.54. Its industry sports an average Forward P/E of 16.61, so one might conclude that SLB is trading at a premium comparatively.
We can also see that SLB currently has a PEG ratio of 1.89. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. The Technology Services industry currently had an average PEG ratio of 1.44 as of yesterday's close.
The Technology Services industry is part of the Business Services sector. This industry currently has a Zacks Industry Rank of 100, which puts it in the top 41% of all 250+ industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.
A Cardinal Health logo appears in this illustration taken August 18, 2025. REUTERS/Dado Ruvic/Illustration Purchase Licensing Rights, opens new tab
CompaniesJuly 20 (Reuters) - Cardinal Health (CAH.N), opens new tab said on Monday it has agreed to buy AdaptHealth's (AHCO.O), opens new tab diabetes health business and medical supply provider Strive Medical in separate deals for about $360 million in total, expanding its home care business.
Here are some details
Jumpstart your morning with the latest legal news delivered straight to your inbox from The Daily Docket newsletter. Sign up here.
The Dublin, Ohio based company said the acquisitions would expand its at-Home Solutions business and build on its earlier purchase of Advanced Diabetes Supply.
AdaptHealth's Diabetes Health business provides devices such as continuous glucose monitors and insulin pumps, along with related services for people with diabetes.
The deal broadens Cardinal Health's reach in diabetes care by adding AdaptHealth's direct-to-patient platform for supplies and support services, and enhances its urology business with the addition of Strive Medical.
Cardinal Health said the deals are expected to add to its adjusted earnings per share in the first 12 months after closing.
Leerink Partners analyst Michael Cherny said the acquisitions were logical, strategic tuck-ins for Cardinal Health, though he noted the diabetes business would need operational improvements to restore growth and profitability. Cherny said Cardinal's scale should help it execute that turnaround.
AdaptHealth separately said Cardinal Health would pay $235 million in cash for the diabetes unit.
Strive Medical serves more than 20,000 people annually and specializes in urology, wound care, ostomy and adult care supplies.
Reporting by Padmanabhan Ananthan in Bengaluru; Editing by Shailesh Kuber
Our Standards: The Thomson Reuters Trust Principles., opens new tab
Cardinal Health (CAH - Free Report) closed at $225.75 in the latest trading session, marking a -1.21% move from the prior day. This change lagged the S&P 500's 0.19% loss on the day. Elsewhere, the Dow saw a downswing of 0.59%, while the tech-heavy Nasdaq depreciated by 0.05%.
The prescription drug distributor's shares have seen an increase of 3.04% over the last month, not keeping up with the Medical sector's gain of 6.06% and outstripping the S&P 500's gain of 0.55%.
Analysts and investors alike will be keeping a close eye on the performance of Cardinal Health in its upcoming earnings disclosure. The company's earnings report is set to go public on August 11, 2026. The company is forecasted to report an EPS of $2.42, showcasing a 16.35% upward movement from the corresponding quarter of the prior year. Our most recent consensus estimate is calling for quarterly revenue of $65.61 billion, up 9.06% from the year-ago period.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $10.77 per share and a revenue of $256.24 billion, indicating changes of +30.7% and +15.12%, respectively, from the former year.
Investors should also pay attention to any latest changes in analyst estimates for Cardinal Health. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 0.29% higher. Cardinal Health is currently sporting a Zacks Rank of #2 (Buy).
In terms of valuation, Cardinal Health is presently being traded at a Forward P/E ratio of 19.02. This represents a premium compared to its industry average Forward P/E of 17.36.
Meanwhile, CAH's PEG ratio is currently 1.12. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. Medical - Dental Supplies stocks are, on average, holding a PEG ratio of 1.87 based on yesterday's closing prices.
The Medical - Dental Supplies industry is part of the Medical sector. This industry, currently bearing a Zacks Industry Rank of 63, finds itself in the top 26% echelons of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.
